Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($1.20) EPS for the quarter, missing the consensus estimate of ($0.90) by ($0.30), Zacks reports. Spyre Therapeutics Stock Performance Shares of SYRE opened at $37.38 on Thursday. Spyre Therapeutics has a fifty-two week low of $2.66 and a […]
Spyre Therapeutics (NASDAQ:SYRE) Issues Quarterly Earnings Results
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE) Releases Quarterly Earnings Results, Misses Estimates By $0 30 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE) Releases Quarterly Earnings Results, Misses Estimates By $0 30 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE) Shares Down 5 1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.